Consultation on the new Therapeutic Goods Order 106 - Data matrix codes and serialisation of medicines

Closed 20 Aug 2020

Opened 2 Jul 2020

Published Responses

View submitted responses where consent has been given to publish the response.


The Therapeutic Goods Administration (TGA) is seeking feedback on proposed requirements for serialisation and the use of data matrix codes on the labels of certain medicines in the Australian supply chain.

To make sure the standard is clear, meaningful and fit for purpose. We are seeking feedback on its suitability and potential impacts.  

Therapeutic Goods (Medicines—Standard for Serialisation and Data Matrix Codes) (TGO 106) Order 2020

Guidance for TGO 106 Medicines—Standard for Serialisation and Data Matrix Codes

Consultation paper

This consultation paper gives further details about data matrix codes and the standard.

Consultation paper - Data matrix codes and serialisation of medicines

Why We Are Consulting

Data matrix codes are an important first step towards a medicine traceability system. Better healthcare - a vision for the use of data matrix codes and medicines traceability explores the potential benefits for our Australian health care system.

What Happens Next

This consultation has now closed. Thank you to all who provided their feedback.

We will be reviewing and analysing all feedback received and updating the results on this page. Watch this space!


  • Non-government organisations
  • State government agencies
  • Commonwealth agencies
  • Local governments
  • Health professionals
  • Community groups
  • Businesses
  • Aged care service providers
  • Health staff
  • HPRG (TGA) Staff
  • Prescription medicines
  • Complementary medicines
  • Over-the-counter medicines
  • Biogicals


  • Hospitals
  • e-Health
  • Health technology
  • Legislation
  • Health insurance
  • Rural health services
  • Regulatory policy
  • Women's health
  • Children's health
  • Home Care
  • Aged Care
  • Residential Aged Care
  • Drugs and substance abuse
  • Immunisation
  • Prescription drugs
  • Preventative health
  • Dental health
  • Strategic Policy
  • Policy Development